Digital Healthcare Partners, a digital healthcare-focused investment firm, and Outsome, a U.S. market entry accelerator, announced on the 21st that they will hold an intensive startup bootcamp in San Francisco.
As domestic healthcare startups with hospitals as their primary customers continue to challenge the U.S. market, the initiative aims to create opportunities for these companies to meet local investors, big tech firms, and university hospitals directly, thereby laying the groundwork for securing investments and clinical validation.
Five companies are participating in this bootcamp: ▲M.A.I.T, an AI-based infant hip dysplasia diagnostic company, ▲Hahaeho, an AI health companion service for seniors and cancer survivors, ▲Foretell My Health, which combines platelet-based liquid biopsy and AI for early cancer detection, ▲Beltrapeutics, a sound-based digital therapeutic device for insomnia, and ▲Seven Point One, which screens high-risk dementia patients through voice analysis.
The participating companies were selected through a 6:1 competition ratio. They will first expand connections with local venture capitals (VCs). On the 23rd, a “VC Roundtable” will be held at the San Francisco office of law firm WilmerHale, featuring LG Technology Ventures, Novo Holdings, and Korea Venture Investment Corporation Silicon Valley.
Efforts to connect with big tech and medical fields are also underway. The startups will visit OpenAI’s headquarters to receive product feedback from its healthcare team and discuss U.S. market expansion strategies, including healthcare AI collaboration and co-selling, at Microsoft’s Silicon Valley campus. They will also participate in Stanford School of Medicine’s “Stanford Biodesign” workshop.
This bootcamp is part of the “Global Market Entry Growth Acceleration Program” organized by Seoul Biohub and Korea Technology Finance Corporation (KOTEC). The first batch, conducted last February, saw seven participating companies achieve over 30 business outcomes, including clinical and distribution contracts, proof-of-concept (PoC) agreements, and investment reviews.
Leave a Reply